SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-14-004190
Filing Date
2014-07-15
Accepted
2014-07-14 17:53:40
Documents
11
Period of Report
2014-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 4132
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5137
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 2169
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 3641
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 4117
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 6001
7 GRAPHIC exhibit99-2x1x1.jpg GRAPHIC 2517
8 GRAPHIC exhibit99-2x1x2.jpg GRAPHIC 1639
9 GRAPHIC exhibit99-2x1x3.jpg GRAPHIC 8269
10 GRAPHIC exhibit99-3x1x1.jpg GRAPHIC 2738
11 GRAPHIC exhibit99-3x1x2.jpg GRAPHIC 2187
  Complete submission text file 0001062993-14-004190.txt   51137
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 000-30082 | Film No.: 14974322
SIC: 2834 Pharmaceutical Preparations